Medicus Sciences Acquisition's common stock is $92M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
As of the most recent data (September 2022), MSAC shows a common stock of $92M. That compares with $92M in the prior-year period — up 0.4% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, MSAC's common stock is now $92M (was $92M) — a 0.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Medicus Sciences Acquisition is outperforming or lagging.
Tracking MSAC's common stock over time shows whether Medicus Sciences Acquisition is scaling, shrinking, or reshaping that part of the business. The current reading is $92M That compares with $92M in the prior-year period — up 0.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this common stock page, Stockcircle has Medicus Sciences Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $92M) with ownership activity and broader fundamentals.